Glenmark Pharmaceuticals Limited
| Report Date | Research house | Description | Reco | At Price | Target Price | UpSide
/DownSide | Download |
|
20-Aug-19
|
KR Choksey
|
Glenmark Pharmaceuticals reported Revenue growth of 7.3% YoY (dow..
|
Buy
|
368
|
454
|
23.4
|
|
|
15-Aug-19
|
Motilal Oswal
|
Miss on all fronts led by muted US/ROW sales & higher interest/ta..
|
Neutral
|
384
|
400
|
4.17
|
|
|
30-May-19
|
Isec
|
Numbers miss on all fronts…
|
Hold
|
549
|
565
|
2.91
|
|
|
24-May-17
|
Nirmal Bang Sec
|
EBITDA performance: EBITDA of Rs 4,438mn was 65.2% and 55.4% belo..
|
|
715
|
|
|
|
|
16-May-17
|
Nirmal Bang Sec
|
Unexpected Dip In Revenues From Zetia Generic Hurts Earnings
|
|
715
|
|
|
|
asdsa
Upcoming Events and Recent Updates
|
11-Sep-19
|
Post ITs (Interesting Article)
-
Glenmark gets USFDA nod for plaque psoriasis treatment drug
( updated on
Sep 11 2019)
|